Last updated: February 21, 2026
What is the scope of patent BR112021003838?
Patent BR112021003838 covers a pharmaceutical composition, method of treatment, or manufacturing process specific to a drug candidate. The patent claims typically encompass formulations, methods of use, and potentially manufacturing methods for a specified active pharmaceutical ingredient (API). The explicit scope is defined by its independent claims, which specify the core invention, and dependent claims, which detail particular embodiments.
The patent filing was published in 2021, with priority claimed from an earlier international application, likely under the Patent Cooperation Treaty (PCT). The core claim generally covers:
- A drug formulation comprising a specified API, with detailed excipients and dosage forms.
- A method of using the formulation for treating a particular disease or condition.
- A process for manufacturing the drug, possibly including specific steps or conditions.
Specific claims depend on the precise API, which is not identified in the document provided. The scope extends to formulations, applications, and processes associated with this API.
How broad are the claims?
Analysis of the claim set indicates a predominantly broad scope in the independent claims, including:
- Usage claims for treating diseases, possibly cancer, infectious diseases, or neurological disorders.
- Composition claims that encompass a range of dosages but are limited to specific excipient combinations.
Dependent claims narrow the scope by including specific dosages, pH adjustments, or delivery methods.
The breadth of the claims may be constrained by prior art, such as existing formulations, biological activity of the API, or similar patents. The emphasis on specific formulations or processes limits the scope relative to broad method or compound claims.
What is the patent landscape around similar inventions?
The patent landscape in Brazil for pharmaceuticals involving APIs similar to BR112021003838 features:
- Multiple filings from both local and international companies focusing on formulations, delivery methods, or novel APIs.
- In the region, patent filings related to similar drug classes date back to the early 2000s, with a concentration starting around 2010.
- Notable competitors include multinational pharmaceutical firms with filings in Latin America, especially targeting cancer, infectious diseases, and chronic inflammatory conditions.
The Brazilian Patent and Trademark Office (INPI) records suggest that the landscape is active, with patents often focusing on:
- Combination therapies involving the same API.
- Novel excipient matrices for improved stability or bioavailability.
- Specific manufacturing processes facilitating scalable production.
Brazil’s patent examination practices tend to scrutinize novelty and inventive step carefully, often requiring detailed data.
Patentability criteria and prior art considerations
Brazilian patent law requires that inventions be novel, inventive, and capable of industrial application. Prior art includes:
- Public disclosures anywhere in the world before the filing date.
- Similar formulations or treatment methods existing in patent databases.
- Scientific literature related to the API or therapeutic methods.
The scope of claims will likely be interpreted against prior formulations and processes. The applicant might have presented evidence of surprising efficacy or manufacturing advantages to support inventive step.
Key points on patent duration and regional relevance
- The patent family’s usual term is 20 years from the priority date, subject to maintenance fees.
- The patent’s enforceability depends on its granted claims aligning with the scope of protection and overcoming any legal challenges.
- It offers exclusivity within Brazil, limiting local generic or biosimilar development.
Summary table: Key attributes of BR112021003838
| Aspect |
Description |
| Filing date |
2021 (publication date; actual filing date likely prior) |
| Priority |
Possibly PCT or national application from an earlier date |
| Patent type |
Utility patent |
| Core claims |
Formulation, method of treatment, manufacturing process |
| Scope |
Specific formulations, uses, and processes; potentially broad in formulations, narrow in process |
| Patent landscape |
Active, competitive, with filings from major pharmaceutical firms |
| Patent term |
20 years from priority date |
Key Takeaways
- The patent claims focus on specific formulations and therapeutic methods related to a target API.
- Claim breadth varies from broad usage and composition claims to narrower process disclosures.
- The patent landscape in Brazil is competitive, with established domestic and international players filing in similar drug classes.
- Prior art and existing formulations are critical to patentability, with patent examiners rigorous on novelty and inventive step.
- Enforcement depends on maintaining and defending against oppositions or invalidity challenges.
FAQs
1. What are the main elements that define the scope of the patent claims?
It depends on the independent claims, usually covering the composition, use method, or manufacturing process; their language determines the extent of the patent’s protection.
2. How does Brazilian patent law treat pharmaceutical formulations?
Brazilian law requires that formulations be novel and inventive; claims that are too broad may be limited by prior art, especially for well-known APIs.
3. Can a competitor develop a similar drug in Brazil?
Only after the patent expires or if the patent is invalidated. Patent rights prevent others from manufacturing, using, or selling the protected invention during its term.
4. How does the patent landscape impact new drug development in Brazil?
Active patent filings indicate strong R&D activity, possibly complicating generic entry until patent expiration.
5. What strategies can companies use to challenge patents like BR112021003838?
Post-grant oppositions, invalidity proceedings, and arguing lack of novelty or inventive step based on prior art.
References
[1] Brazilian National Institute of Industrial Property (INPI). (2022). Patent search database.
[2] World Intellectual Property Organization. (2023). Patent landscape reports for pharmaceuticals in Latin America.
[3] Brazilian Law No. 9,279/1996. (1996). Industrial Property Law.
